The Virginia Tech Corporate Research Center is excited to welcome Bacchus Therapeutics, Inc. to COgro Labs. Bacchus Therapeutics, Inc. is a biotech company that exploits cancer’s hypermetabolic state by targeting specific cancer metabolic pathways. Their team has developed innovative small molecules that target fat metabolism, causing cancer regression in preclinical mouse and human studies. Bacchus Therapeutics, Inc. is one of three awardees of the Advancing Oncology InnoVAtion QuickFire Challenge.
Meet the Researcher
Arvin Gouw, Ph.D., a Cancer Nanotechnology Fellow at Stanford University School of Medicine, has 10 years of experience studying cancer metabolism. He received his B.A. and M.A. from UC Berkeley, his M.Phil. from the University of Pennsylvania, and his Ph. D. from Johns Hopkins School of Medicine.
About the Advancing Oncology InnoVAtion QuickFire Challenge
Johnson & Johnson Innovation, in collaboration with Carilion Clinic Innovation, Verge Alliance (with support from City of Roanoke), and Virginia Tech Corporate Research Center (VTCRC), announced at the Harnessing the Potential of Antibody Drug Conjugates (ADC) in Oncology event at JLABS @ Washington D.C. that Bacchus Therapeutics, Luminary Therapeutics, and QurCan Therapeutics Inc., have been selected as the awardees in the Advancing Oncology InnoVAtion QuickFire Challenge.
The challenge invited innovators from across the globe with an active interest in the Virginia innovation ecosystem to submit potential solutions aiming to transform patient outcomes in oncology in adult populations with potential applications in pediatric oncology. The awardees hope to nurture Virginia’s outstanding innovation ecosystem and spearhead innovative solutions to enhance the quality of life for cancer patients across the globe.
The awardees will receive grant funding from a total pool of $300,000, VTCRC residency for one year which includes one bench & workstation, access to the global Johnson & Johnson Innovation – JLABS network, and mentorship from experts across The Johnson & Johnson Family of Companies. *
*Subject to terms and conditions of applicable Quickfire Challenge and execution of all relevant and necessary award agreements
About COgro Labs
COgro Labs is located at the Virginia Tech Corporate Research Center, where researchers work alongside some of the world’s best innovators in autonomous technology, biotechnology, software and cybertech, and aerospace and defense. COgro Labs lowers the barrier to entry to the research park by providing turnkey lab space at an affordable rate.
JLABS and VTCRC
Marquee programming and opportunity collide to meet the needs of emerging startups and existing biotech companies. A collaboration between the VTCRC and JLABS will provide innovators with access to expert mentoring, programming, and resources. Companies can apply to participate with access to labs in Blacksburg and Washington, D.C.